Rajkumar Patil
Chief Scientific OfficerDr. Rajkumar Patil, Ph.D, also known as Raj, serves as Chief Scientific Officer at OKYO Pharma Limited since March 2021. Dr. Patil ophthalmic and pharmaceutical R&D experience. Dr. Patil worked with Ora Inc, as Vice President of Research & Development, where he was responsible for driving all anterior and posterior segment research of Ora’s R&D Institute. During 2013-2018, he worked at iVeena Delivery Systems as Vice President of Advanced Ocular Delivery Systems. His term at iVeena included a sabbatical in Singapore, where he served as an Associate Professor of Ophthalmology at DUKE/NUS Medical School and Principal Investigator at Singapore Eye Research Institute. Dr. Patil has also held several leadership roles at Alcon/Novartis Institute of Biomedical Research from 2004-2013, including Associate Director of Research and Head of Molecular Pharmacology glaucoma and retina research. Before joining Alcon, Dr. Patil served as an Associate Professor of Ophthalmology, Cell Biology & Genetics at University of Nebraska Medical Centre in Omaha and as an Assistant Professor of Ophthalmology, Molecular Biology & Pharmacology at Washington University in St. Louis. He is the recipient of the Olga Keith Wiess Special Scholar Award from the Research to Prevent Blindness Foundation and NIH Director’s New Innovator Award. Dr Patil has authored over 50 peer-reviewed research articles and serves as reviewer and editorial Board Member for numerous journals and is frequently invited to lecture at academic and industry events. Dr. Patil received his PhD in Biochemistry from National Chemical Laboratory/University of Pune, India and completed his postdoctoral training in Biochemistry and Molecular Biology at the University of Michigan, Ann Arbor, MI.
Positions
- Company NameOKYO Pharma LimitedStock CodeOKYOPositionChief Scientific OfficerColleagues
- RJRobert J. DempseyCEO & Executive Director
- GMGabriele Marco Antonio CerroneNon-Executive Chairman
- KSKeeren ShahChief Financial Officer
- GSGary S. JacobChief Development Officer & Director
- FMFlavio MantelliChief Medical Officer
- WJWilly Jules SimonSenior Independent Non-Executive Director
- JPJohn Patrick BrancaccioIndependent Non-Executive Director
